Neuland Laboratories Ltd. (NEULANDLAB) Share Price Rises 3.16% Today

Neuland Laboratories Ltd. traded at Rs 22,895.40, up 3.16% today, taking its market capitalisation to Rs 29,308.02 crore.

Neuland Laboratories Ltd. Share Price moved higher to Rs 22,895.40 on 11 August 2026, rising 3.16% or Rs 701.70 for the day. With market capitalisation at Rs 29,308.02 crore, the stock entered the session’s notable gainers list after a same-day price rise that qualified under its Large Cap category. For readers tracking Neuland Laboratories Ltd. Share Price Today, the move stood out because it combined a clear gain over the previous close of Rs 22,193.70 with an intraday range that stretched to Rs 23,135.95.

The supplied data confirms the price event, the scale of the move and the trading activity behind it. It does not establish a company-specific catalyst, so today’s coverage stays focused on verified market data, valuation context that is available, and how the stock compares with the broader Healthcare basket and selected listed peers. That makes this Neuland Laboratories Ltd. Stock News update especially relevant for investors scanning Top Gainers Today, Market Movers and Stocks in News across the Indian Stock Market.

From a market-structure perspective, the stock opened at Rs 22,100.95, also the day’s low, and then advanced sharply enough to maintain gains into the afternoon. Total traded volume reached 1,00,979 shares across exchanges, while turnover stood at Rs 7.12 crore. In this Univest analysis, the immediate questions are straightforward: what exactly happened in today’s trade, how strong was the underlying price action, and what does the available sector and peer data add to the Neuland Laboratories Ltd. Share Price Rise narrative?

Neuland Laboratories Ltd. (NEULANDLAB) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 22,895.4
Previous Close	Rs 22,193.7
Today's Change	+Rs 701.7 (+3.16%)
Day Open	Rs 22,100.95
Day High	Rs 23,135.95
Day Low	Rs 22,100.95
Current Volume (BSE)	3,109
BSE Traded Volume	3,109
NSE Traded Volume	97,870
Combined NSE + BSE Volume	1,00,979
Turnover	Rs 7.12 crore
Market Capitalisation	Rs 29,308.02 crore
Market Cap Category	Large Cap

Neuland Laboratories Ltd. (NEULANDLAB) traded at Rs 22,895.4. versus the previous close of Rs 22,193.7, a rise of 3.16%. The stock opened at Rs 22,100.95, reached Rs 23,135.95, touched Rs 22,100.95. Reported volume was 3,109.

Neuland Laboratories Ltd. (NEULANDLAB) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 29,308.02 crore

Neuland Laboratories Ltd. Fundamental Analysis in this update is necessarily centred on verified size and market context rather than a full ratio set, because the supplied dataset establishes the company’s current market capitalisation and today’s trading metrics while sector benchmark figures provide the comparative backdrop. That still offers useful perspective on why investors are paying attention.

The first anchor is scale. Neuland Laboratories Ltd. Market Cap stands at Rs 29,308.02 crore, placing it far above the Healthcare sector benchmark median market capitalisation of Rs 142.30 crore and also above the benchmark average of Rs 472.15 crore across 197 companies in the same sector snapshot. Even the maximum market capitalisation in that benchmark basket is Rs 3,032.97 crore, which is far below Neuland Laboratories Ltd.’s current scale. That gap matters because market capitalisation indicates company size, not quality, and today’s price rise happened in a stock that is substantially larger than many benchmark constituents.

Today’s turnover of Rs 7.12 crore and total volume of 1,00,979 shares provide the trading context behind the move. These are not profitability or cash-flow metrics, but they do show that the Neuland Laboratories Ltd. Share Price Rise was accompanied by active market participation rather than being defined by a single small print. In Stock Market Today terms, that keeps the move relevant for investors watching liquidity-backed price action.

The available dataset does not establish a company-specific earnings trigger, margin shift or balance-sheet event behind the rise, so this Neuland Laboratories Ltd. Stock Analysis stays disciplined: the confirmed facts are the 3.16% day gain, the Rs 701.70 absolute increase, the close-to-high trading pattern and the company’s large market value within the Healthcare universe. For readers following Neuland Laboratories Ltd. Financial Results or Neuland Laboratories Ltd. Earnings more broadly, today’s move should therefore be read as a market event first and a fundamental signal only in the limited sense that a large-cap Healthcare name drew meaningful attention without sacrificing price discipline. From here, the most useful next layer is sector and benchmark comparison.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Benchmark Median P/E	25.7x
Benchmark Average P/E	96.66x
Benchmark P/E Range	3.08x to 3,396.3x
Benchmark Median P/B	1.94x
Benchmark Median ROE	10.92%
Benchmark Median ROCE	13.38%
Company Market Capitalisation	Rs 29,308.02 crore
Benchmark Median Market Cap	Rs 142.3 crore

Neuland Laboratories Ltd. (NEULANDLAB) is classified under sector: Healthcare.

Track today's top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.

The Healthcare sector snapshot provides the clearest benchmark for interpreting today’s move. It shows a broad valuation and profitability range across 197 same-sector companies, allowing investors to place Neuland Laboratories Ltd. within a much larger listed ecosystem even when company-specific valuation ratios are not part of the supplied event data.

Neuland Laboratories Ltd. sits within the Healthcare sector, and the benchmark scope used here covers the same sector across 197 companies. That breadth matters because it reveals just how dispersed valuations and returns can be within one market bucket. In this benchmark, P/E data is available for 156 companies, with a median of 25.7 and an average of 96.66. The range runs from 3.08 at the low end to 3,396.3 at the high end. P/B data is available for 196 companies, with a median of 1.94 and an average of 2.65, spanning from -16.9 to 15.98.

Profitability is similarly varied. The sector’s ROE median is 10.92 and average is 15.47 across 196 companies, while ROCE shows a median of 13.38 and an average of 17.78. The market-cap distribution is even more striking: the sector median market capitalisation is Rs 142.30 crore, the average is Rs 472.15 crore, the minimum is Rs 4.08 crore and the maximum is Rs 3,032.97 crore. Against that backdrop, Neuland Laboratories Ltd. Market Cap of Rs 29,308.02 crore stands out as exceptionally large relative to the benchmark sample shown.

What does that tell investors? First, Neuland Laboratories Ltd. Share Price News today is not occurring in a marginal company at the edge of the Healthcare listed space. Second, it highlights that sector valuation bands are wide, so benchmark averages alone should not be overread. Third, the company’s size means its inclusion in Top Gainers Today has more screening significance than a similar percentage move in a very small stock. In Univest’s reading, the sector data does not explain why the stock rose on the day, but it does explain why the market notices the move quickly: this is a sizeable Healthcare counter operating in a sector with very broad valuation and profitability dispersion.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	3,032.97	0	0.76	-2.89	-0.26
Hikal Ltd.	HIKAL	2,799.54	0	2.32	15.22	16.15
Kwality Pharmaceuticals Ltd.	KPL	2,707.2	40.09	9.77	28.21	26.35
Beta Drugs Ltd.	BETA	2,631.45	66.92	10.59	18.65	22.17
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,601.85	34.14	7.04	-2.6	16.92

Neuland Laboratories Ltd. (NEULANDLAB) has a market capitalisation of Rs 29,308.02 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

The peer set shows a cluster of Healthcare names that are much smaller by market capitalisation than Neuland Laboratories Ltd. It also highlights how mixed valuation and return profiles are across comparable listed companies, which is useful when assessing whether today’s price rise is happening in a broadly expensive, cheap or uneven peer landscape.

Among the supplied peers, Dishman Carbogen Amcis Ltd. has a market capitalisation of Rs 3,032.97 crore, Hikal Ltd. stands at Rs 2,799.54 crore, Kwality Pharmaceuticals Ltd. at Rs 2,707.20 crore, Beta Drugs Ltd. at Rs 2,631.45 crore and Dr Agarwals Eye Hospital Ltd. at Rs 2,601.85 crore. Panacea Biotec Ltd. is at Rs 2,531.49 crore, Sai Parenteral's Ltd. at Rs 2,513.58 crore, Solara Active Pharma Sciences Ltd. at Rs 2,422.79 crore, NGL Fine-Chem Ltd. at Rs 2,118.60 crore and Venus Remedies Ltd. at Rs 2,068.61 crore. On size alone, Neuland Laboratories Ltd. at Rs 29,308.02 crore is far above every supplied peer.

The profitability picture across peers is uneven. Hikal shows ROE of 15.22 and ROCE of 16.15, while Kwality Pharmaceuticals posts ROE of 28.21 and ROCE of 26.35. Beta Drugs comes in at ROE 18.65 and ROCE 22.17, and NGL Fine-Chem shows ROE 27.90 with ROCE 33.91. At the weaker end, Dishman Carbogen Amcis reports ROE of -2.89 and ROCE of -0.26, while Dr Agarwals Eye Hospital shows ROE of -2.6 despite ROCE of 16.92. Panacea Biotec’s ROE is 0 with ROCE of 5.36, and Venus Remedies posts ROE 9.85 and ROCE 7.89.

Valuation multiples where supplied also vary materially. Kwality Pharmaceuticals trades at P/E 40.09 and P/B 9.77, Beta Drugs at P/E 66.92 and P/B 10.59, Dr Agarwals Eye Hospital at P/E 34.14 and P/B 7.04, Sai Parenteral's at P/E 181.97 and P/B 3.36, NGL Fine-Chem at P/E 44.48 and P/B 6.5, and Venus Remedies at P/E 17.49 and P/B 2.96. Hikal’s P/B is 2.32, Solara’s is 1.93 and Dishman’s is 0.76. This reinforces a key point in Univest’s Neuland Laboratories Ltd. Stock News coverage: the Healthcare peer field is highly diverse, and today’s price rise occurred against a backdrop where company size, returns and valuation signals differ sharply across the listed pack.

Why Investors Are Watching Neuland Laboratories Ltd.

Investors are watching Neuland Laboratories Ltd. Share Price because today’s move combined a qualifying large-cap gain, a close near the upper end of the day’s range, meaningful turnover and a market capitalisation that dwarfs the benchmark and peer set supplied in this event snapshot. In Share Market Today screens, those factors tend to elevate visibility quickly.

• Verified price action: the stock rose Rs 701.70, or 3.16%, to Rs 22,895.40 from a previous close of Rs 22,193.70.
• Intraday structure: it opened at Rs 22,100.95, which was also the day’s low, and climbed to Rs 23,135.95.
• Trading activity: total volume reached 1,00,979 shares, with 97,870 shares on NSE and 3,109 shares on BSE, while turnover stood at Rs 7.12 crore.
• Scale: market capitalisation of Rs 29,308.02 crore keeps the stock relevant in large-cap market news and stock updates.
• Sector backdrop: the Healthcare benchmark spans 197 companies with wide valuation and profitability dispersion.

What investors may monitor next is whether Neuland Laboratories Ltd. Share Price continues to hold above the previous close after such a strong intraday recovery from the open-low setup, and whether future company filings provide a verified trigger that explains today’s momentum. Until then, the confirmed story remains a notable price rise in a large Healthcare stock, as captured in this Univest market update.

About Neuland Laboratories Ltd.

Neuland Laboratories Ltd. is covered here as a listed Healthcare company, and that sector identity is the clearest verified business context available in the supplied dataset. In market classification terms, that places the company inside one of India’s most actively tracked spaces for Stock News, Sector Analysis and peer-based financial comparison.

The broader Healthcare universe used in this article includes pharmaceutical and drug companies such as Dishman Carbogen Amcis, Hikal, Kwality Pharmaceuticals, Beta Drugs, Panacea Biotec, Sai Parenteral's, Solara Active Pharma Sciences, NGL Fine-Chem and Venus Remedies, along with Hospital & Healthcare Services exposure through Dr Agarwals Eye Hospital. That matters because investors often interpret a company’s Share Price movement not only through standalone trading data but also through the type of listed ecosystem in which it operates.

For Neuland Laboratories Ltd., the immediate company overview available to readers is therefore sector-led rather than description-led: it is part of Healthcare, it has achieved a market capitalisation of Rs 29,308.02 crore, and its stock activity on 11 August 2026 made it one of the more visible market movers in the space. For investors using Univest for Neuland Laboratories Ltd. Share Price Live tracking, that basic context is still useful because it positions the stock within a competitive listed universe where peer valuation, profitability and size vary significantly across the board.

Track Neuland Laboratories Ltd. Share Price on Univest

Use Neuland Laboratories Ltd. (NEULANDLAB) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.

Readers who want to follow Neuland Laboratories Ltd. Share Price beyond today’s move can use Univest to track live share price changes, 52-week levels, technical indicators when available, fundamental ratios, market capitalisation, shareholding pattern, sector positioning and broader market insights. For a stock that has appeared in today’s top gainer screens, consistent tracking matters more than reacting to one session in isolation.

Univest helps investors organise Neuland Laboratories Ltd. Share Price Today data alongside turnover, exchange-wise volume, peer comparison and sector context in one place. That makes it easier to follow Neuland Laboratories Ltd. Stock News, compare the stock with Healthcare peers and monitor how future market updates interact with price action already seen in this session.

Frequently Asked Questions

What is Neuland Laboratories Ltd. Share Price today?

Ans. Neuland Laboratories Ltd. Share Price was Rs 22,895.40 at the time of this update. The stock was up Rs 701.70 or 3.16% from the previous close of Rs 22,193.70 on 11 August 2026.

Why is Neuland Laboratories Ltd. Share Price rising today?

Ans. The supplied data confirms that the stock rose 3.16% in the session and qualified as a notable price rise in its Large Cap category. The dataset verifies the move and trading activity, but does not establish a company-specific catalyst.

What was the intraday range for Neuland Laboratories Ltd. today?

Ans. The stock opened at Rs 22,100.95, which was also the day’s low, and climbed to an intraday high of Rs 23,135.95. That pattern showed a strong rebound from the opening level during the session.

How much did Neuland Laboratories Ltd. gain in rupee terms?

Ans. Neuland Laboratories Ltd. added Rs 701.70 during the session. In percentage terms, that translated into a 3.16% rise over the previous close of Rs 22,193.70, taking the stock price to Rs 22,895.40.

What is the market capitalisation of Neuland Laboratories Ltd.?

Ans. Neuland Laboratories Ltd. had a market capitalisation of Rs 29,308.02 crore in this update. That places it well above the Healthcare benchmark median of Rs 142.30 crore and average of Rs 472.15 crore.

How much volume was traded in Neuland Laboratories Ltd. today?

Ans. Total traded volume stood at 1,00,979 shares. Exchange-wise, BSE volume was 3,109 shares and NSE volume was 97,870 shares, showing that most trading activity in the stock was concentrated on NSE.

What was the turnover in Neuland Laboratories Ltd. shares today?

Ans. Turnover in Neuland Laboratories Ltd. shares was Rs 7.12 crore in this session. Along with the 3.16% gain and total volume of 1,00,979 shares, that indicates meaningful participation behind the day’s price action.

Which sector does Neuland Laboratories Ltd. belong to?

Ans. Neuland Laboratories Ltd. belongs to the Healthcare sector in the supplied dataset. The benchmark used for comparison covers 197 same-sector companies, making sector-level valuation and market-cap context useful for interpreting the move.

How does Neuland Laboratories Ltd. compare with Healthcare peers by size?

Ans. At Rs 29,308.02 crore market capitalisation, Neuland Laboratories Ltd. is much larger than the supplied peers, which range from Rs 2,068.61 crore for Venus Remedies to Rs 3,032.97 crore for Dishman Carbogen Amcis.

Where can investors track Neuland Laboratories Ltd. Share Price updates?

Ans. Investors can track Neuland Laboratories Ltd. Share Price on Univest for live price moves, market capitalisation, sector context, peer comparison, 52-week levels and broader stock updates related to today’s market action.